Patient Guide: A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 176 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT00781612
Status: ACTIVE_NOT_RECRUITING
Condition: Neoplasm Metastasis
Phase: PHASE2

Where You Can Participate

This study is available at 176 locations across the country.

Top locations include:
  • • Duarte, California
  • • Redondo Beach, California
  • • San Francisco, California
  • • And 173 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies - Join Clinical Trial NCTNCT00781612

How to Join This Clinical Trial - NCTNCT00781612

Learn how to participate in this PHASE2 trial studying an investigational therapy for Neoplasm Metastasis. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Neoplasm Metastasis. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Neoplasm Metastasis
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT00781612 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 176 locations. Find a study site near you:

Clinical Research Site

Duarte, California 91010 - United States

Status: Contact for availability

Clinical Research Site

Redondo Beach, California 90277 - United States

Status: Contact for availability

Clinical Research Site

San Francisco, California 94115 - United States

Status: Contact for availability

Clinical Research Site

San Luis Obispo, California 93454 - United States

Status: Contact for availability

Clinical Research Site

Santa Monica, California 90404 - United States

Status: Contact for availability

Clinical Research Site

Stanford, California 94305-5456 - United States

Status: Contact for availability

Clinical Research Site

Walnut Creek, California 94596 - United States

Status: Contact for availability

Clinical Research Site

Aurora, Colorado 80045 - United States

Status: Contact for availability

Clinical Research Site

Aurora, Colorado 80045 - United States

Status: Contact for availability

Clinical Research Site

Denver, Colorado 80220 - United States

Status: Contact for availability

And 166 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Neoplasm Metastasis:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships